BioCardia Reports First Quarter 2024 Business Highlights and Financial Results
SUNNYVALE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for th...
United States Peter Altman Biocardia Inc Maryland Stem Cell Research Fund European Society Of Cardiology Heart Failure Congress Medicaid Services
Source: businessinsider.com